ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1156

Four-Year Impact of the COVID-19 Pandemic on Mortality and Hospitalization Trends among Patients on Maintenance Dialysis from a National US Dialysis Provider

Session Information

  • COVID-19
    October 24, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Shieu, Monica, Dialysis Clinic Inc, Nashville, Tennessee, United States
  • Li, Nien Chen, Dialysis Clinic Inc, Nashville, Tennessee, United States
  • Manley, Harold, Dialysis Clinic Inc, Nashville, Tennessee, United States
  • Harford, Antonia, Dialysis Clinic Inc, Nashville, Tennessee, United States
  • Hsu, Caroline M., Tufts Medical Center, Boston, Massachusetts, United States
  • Weiner, Daniel E., Tufts Medical Center, Boston, Massachusetts, United States
  • Miskulin, Dana, Tufts Medical Center, Boston, Massachusetts, United States
  • Johnson, Doug, Dialysis Clinic Inc, Nashville, Tennessee, United States
  • Lacson, Eduardo K., Dialysis Clinic Inc, Nashville, Tennessee, United States
Background

Longitudinal trends in mortality and hospitalization rates during the COVID-19 pandemic period (2020-2023) vs. prior two years (2018-2019) among patients receiving maintenance dialysis from a national provider were described.

Methods

Adult maintenance dialysis patients at Dialysis Clinic, Inc. between 1/1/2018 to 12/31/2023 were included. Hospitalization stays over two midnights and death events were obtained from electronic medical record. COVID-19 hospitalization and death were defined as within 30 days and 90 days of a COVID-19 diagnosis, respectively.

Results

The study included 41,257 patients. All-cause mortality among prevalent patients receiving dialysis decreased by 15.4%, from 16.9 to 14.3 (per 1000 person-months) between 2018-2023, with a spike in 03/2020 when the pandemic started. Mortality peaked that winter (19.4 per 1000 person-months) until the availability of COVID-19 vaccines in early 2021 (Fig 1a). All-cause hospitalization rates decreased between 2018-2023. There was a sudden drop in hospitalization rates when the pandemic began (1.61 from 01/2018 to 1.18 03/2020 and 1.01 from 04/2020 per person-year); these rates never recovered to the overall rates observed prior to the pandemic (Fig 1b).

Conclusion

The pandemic has impacted mortality and hospitalization rates among patients on maintenance dialysis, with a drastic increase in all-cause mortality vs. a sudden drop in all-cause hospitalization when the pandemic started. All-cause mortality and hospitalization rates, 2018-2021, are lower than the rates in 2023 USRDS. The profound impact of vaccination in reducing severe outcomes from COVID-19 is evident. Strategies to maintain updated vaccination status to prevent COVID-19-related hospitalization and death in this high-risk population are warranted.